Search clinical trials for: Dendritic Cell based p53 Vaccine

Total 1008 results

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Active, not recruiting

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Coronavirus Disease 2019

China
NewLink Genetics Corporation
National Cancer Institute (NCI)

Completed

Vaccine Treatment for Advanced Non-Small Cell Lung Cancer

Lung Neoplasms | Adenocarcinoma of Lung | Non-small Cell Carcinoma | Squamous Cell Carcinoma | Large Cell Carcinoma

United States
Opexa Therapeutics, Inc.

Completed

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)

Relapsing-Remitting Multiple Sclerosis

United States
The New York Academy of Medicine

Unknown

Rapid Vaccination of Hard-To-Reach Populations

Influenza

United States
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

Neoplasms, Pancreas

China
Janssen Vaccines & Prevention B.V.

Terminated

A Study of Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older

Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention

United States
The Reading Hospital and Medical Center

Completed

Comparison of Educational Methods for Teaching Peripheral Blood Smears (PBS)

Hematologic Diseases

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Hunan Provincial Center for Disease Control and Prevention; Guizhou Center... and other collaborators

Recruiting

Safety Study of COVID19 Vaccine on the Market

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)

COVID-19

China
Novartis Vaccines

Completed

Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above

Influenza

Germany
University of Alabama at Birmingham
ViraCor Laboratories

Withdrawn

COVID Vaccine Immunity in Kidney Transplant Recipients

End Stage Renal Disease | Kidney Transplant; Complications
GlaxoSmithKline

Completed

An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa

Malaria

Burkina Faso, Kenya, Tanzania
PrimeVax Immuno-Oncology Inc.
Walter Reed Army Institute of Research (WRAIR)

Not yet recruiting

Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanoma

Advanced Melanoma
Washington University School of Medicine

Withdrawn

Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small-Cell-Lung
Hassane M. Zarour, MD
National Cancer Institute (NCI)

Completed

CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors

NY-ESO-1-expressing Tumors

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer

Lung Cancer

United States
Fundación Oftalmológica de Santander Clínica Carlos...

Completed

Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia

Diabetes Mellitus | Chronic Limb-threatening Ischemia

Colombia
Beijing Biohealthcare Biotechnology Co.,Ltd

Unknown

DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment

Gastric Cancer

China
Massachusetts General Hospital

Completed

Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

United States
Yuehua Huang
Sun Yat-sen University; Nanfang Hospital of Southern Medical University

Unknown

"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
University of Pennsylvania

Active, not recruiting

Dendritic Cell Vaccination in Patients With Advanced Melanoma

Melanoma

United States
University Hospital Carl Gustav Carus

Completed

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

Multiple Myeloma | Plasmocytoma

Germany
Novartis
Novartis Vaccines

Completed

Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup

Influenza

Poland
University Hospital, Antwerp
Roche Pharma AG; Algemeen Ziekenhuis Maria Middelares; Kom Op Tegen Kanker; Vitaz

Recruiting

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma (Immuno-MESODEC)

Malignant Pleural Mesothelioma

Belgium
GlaxoSmithKline

Completed

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

Infections, Papillomavirus

United States, Spain, Finland, Germany, Taiwan, Belgium, Philippines, Canada, Australia, United Kingdom, Thailand, Brazil, Italy, Mexico
Inge Marie Svane

Completed

Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer

Prostatic Neoplasms

Denmark
Oxford Immunotec

Terminated

Lyme Test Indication Combinations (LyTIC) Study (LyTIC)

Lyme Disease

United States
Stanford University
National Cancer Institute (NCI)

Completed

Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells

Multiple Myeloma

United States
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

SARS-CoV2 Infection

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Shulan (Hangzhou) Hospital

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (COVID-19)

COVID-19

China
PT. Kimia Farma (Persero) Tbk

Active, not recruiting

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

COVID-19

Indonesia
Talaris Therapeutics Inc.
Northwestern University

No longer available

Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)

Renal Failure

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

Coronavirus Disease 2019

China
Chulalongkorn University

Unknown

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Primary Immunodeficiency

Thailand
Novartis Vaccines

Completed

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

Rabies

India
MAXVAX Biotechnology Limited Liability Company
Henan Center for Disease Control and Prevention

Active, not recruiting

Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above

Herpes Zoster

China
University of Manitoba
Inovio Pharmaceuticals

Completed

DNA-based Influenza Vaccine in the Elderly

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Influenza, Human | Orthomyxoviridae Infections

Canada
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Recruiting

Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

Coronavirus Disease 2019

China
Ruijin Hospital

Recruiting

Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers

Covid19 | SARS-CoV-2 Infection

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Completed

Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above (COVID-19)

COVID-19 | COVID-19 Pneumonia

United Arab Emirates
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; Meilleur Accès aux Soins de Santé (M.A....

Completed

Extended Dose Intervals With Oral Cholera Vaccine in Cameroon

Cholera Vaccination Reaction | Adverse Reaction to Cholera Vaccine

Cameroon
Novartis Vaccines

Completed

Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine

Swine-Origin Influenza A H1N1 Virus

Japan
Abbott Biologicals
Quintiles, Inc.

Completed

Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination

Influenza

United States
Cancer Institute and Hospital, Chinese Academy...
Hubei Provincial Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

SARS-CoV-2 Infection

China
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

SARS-CoV-2 Infection

China
Dana-Farber Cancer Institute
National Institutes of Health (NIH); Brigham and Women's Hospital

Completed

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts

United States
Solvay Pharmaceuticals

Completed

Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years

Healthy
University of Maryland, Baltimore

Completed

Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine

Risk Reduction

United States
University of Louisville

Terminated

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Neuroectodermal Tumors, Primitive | Medulloblastoma | Gliomas

United States
Gradalis, Inc.

Completed

Salvage Ovarian FANG™ Vaccine + Carboplatinum

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States

Search clinical trials for: Dendritic Cell based p53 Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations